| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $5.0M | -28.1% | -30.1% |
| SG&A Expense | $3.0M | -2.6% | -4.1% |
| Operating Income | -$8.0M | +20.3% | +22.2% |
| Income Tax | $0 | — | — |
| Net Income | -$10.1M | +4.5% | +46.5% |
| EPS (Basic) | -$0.60 | +9.1% | +56.8% |
| EPS (Diluted) | -$0.60 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $20.6M | -6.7% | -20.8% |
| Current Assets | $21.5M | -5.0% | -30.0% |
| Total Assets | $28.3M | -4.2% | -26.3% |
| Current Liabilities | $6.5M | -34.3% | -27.8% |
| Long-term Debt | $9.7M | +4.1% | — |
| Total Liabilities | $24.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$30.2M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $31.8M | — | — |
| Free Cash Flow | -$30.2M | — | — |
| +56.8% |
| -11.6% |
| -57.4% |
| Stockholders' Equity | $3.8M | +108.1% | +120.1% |